TP53 and lung carcinoma: These findings are consistent with the p53 inactivation observed in various cancer tissues, including acute myeloid leukemia and lung cancer (Hu & Chen, 2015; Simonetti et al., 2019); this effect may be ascribed to CDC20 up-regulation.